6 Feasibility of breast conserving surgery in multifocal breast cancers: Kadioʇlu H, Yücel S, Yildiz S, et al (Bezmialem Vakif Üniversitesi, Fatih/Istanbul, Turkey) Am J Surg 208:457-464, 2014

7 Issues and difficulties of the management of expensive drugs not included in the list in addition for a hospital dealing with cancers

8 Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

9 Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

10 Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

11 Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers.

12 Multiple roles and regulatory mechanisms of the transcription factor GATA6 in human cancers.

13 Virus-associated human cancers in Moroccan population: From epidemiology to prospective research

14 The impact of the Orphan Drug Act on Food and Drug Administration-approved therapies for rare skin diseases and skin-related cancers

15 Impact of histologic variants on the oncological outcomes of patients with upper urinary tract cancers treated with radical surgery: a multi-institutional retrospective study.

16 Impact of palliative care on quality of end-of-life care among Brazilian patients with advanced cancers.

17 Prevalence and Pattern of Late-Stage Presentation in Women with Breast and Cervical Cancers in Lagos University Teaching Hospital, Nigeria.

18 Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases.

19 SOR guidelines for concomitant chemoradiotherapy for patients with uterine cervical cancers: evidence update bulletin 2004.

20 Protective potential of miR-146a-5p and its underlying molecular mechanism in diverse cancers: a comprehensive meta-analysis and bioinformatics analysis.

21 A phase III randomised clinical trial of perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB): study protocol.

22 Dark-matter matters: Discriminating subtle blood cancers using the darkest DNA.

23 Anti-GPC3 Antibody Tagged Cationic Switchable Lipid-Based Nanoparticles for the Co-Delivery of Anti-miRNA27a And Sorafenib in Liver Cancers.

24 Myoferlin, a multifunctional protein in normal cells, has novel and key roles in various cancers.

25 Merkel cell carcinoma of the head and neck and associated second primary cancers: report of three cases.

26 Primarily Surgical Treatment of Cervical Cancers Diagnosed in Stages IA–IIA at Can Tho Oncology Hospital: An Overview of 9 Years’ Experience 2000–2008

27 [Medical treatment in ovarian cancers newly diagnosed: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].

28 Patient-Centered Insights on Treatment Decision Making and Living with Acute Myeloid Leukemia and Other Hematologic Cancers.

29 Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline.

30 Connections between metabolism and epigenetics in cancers.

31 Risk of Endometriosis and Subsequent Ovary and Breast Cancers in Nurses: A Population-Based Cohort Study in Taiwan.

32 Frequency of chemoradiotherapy-induced mucositis and related risk factors in patients with the head-and-neck cancers: A survey in the North of Iran.

33 Publisher Correction: Shared heritability and functional enrichment across six solid cancers.

34 Quality of Care Indicators for Head and Neck Cancers: The Experience of the European Project RARECAREnet.

35 Dosimetric and Monte Carlo verification of jaws-only IMRT plans calculated by the Collapsed Cone Convolution algorithm for head and neck cancers.

36 Benchmarking health-related quality of life in thyroid cancer versus other cancers and United States normative data.

37 Therapeutic inhibition of Mcl-1 blocks cell survival in estrogen receptor-positive breast cancers.

38 Potential use of edaravone to reduce specific side effects of chemo-, radio- and immuno-therapy of cancers.

39 Shared heritability and functional enrichment across six solid cancers.

40 Endocrine and Metabolic Disorders in Survivors of Childhood Cancers and Health-Related Quality of Life and Physical Activity

41 Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.

42 Two Receptors, Two Isoforms, Two Cancers: Comprehensive Analysis of KIT and TrkA Expression in Neuroblastoma and Acute Myeloid Leukemia.

43 Synchronous Onset of Breast and Pancreatic Cancers: Results of Germline and Somatic Genetic Analysis

44 Evaluation of the Validity of a Nonlinear J-Shaped Dose-Response Relationship in Cancers Induced by Exposure to Radiofrequency Electromagnetic Fields.

45 Optoacoustic imaging and gray-scale us features of breast cancers: Correlation with molecular subtypes

46 Molecular features of premenopausal breast cancers in Latin American women: Pilot results from the PRECAMA study

47 Differences in molecular features of triple-negative breast cancers based on the age at diagnosis

48 Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs

49 Population attributable fractions of tobacco related cancers in Turkey and seven geographical regions

50 Thermo-responsive Fluorescent Nanoparticles for Multimodal Imaging and Treatment of Cancers.

51 Surface Mould Brachytherapy for Skin Cancers: The British Columbia Cancer Experience.

52 A survey of cancer and occupation in young and middle aged men. I. Cancers of the respiratory tract.

53 Corrigendum to “DAB2IP with tumor-inhibiting activities exhibits frameshift mutations in gastrointestinal cancers” (Pathology - Research and Practice (2018) 214(12) (2075–2080), (S0344033818309245), (10.1016/j.prp.2018.10.005))

54 Trends and Analysis of Cancer Incidence for Common Male and Female Cancers in the Population of Punjab Province of Pakistan during 1984 to 2014.

55 Chemotherapy in the definitive management of oral cancers: Where do we stand today?

56 CXCL11-CXCR3 axis mediates tumor lymphatic crosstalk and inflammation induced tumor promoting pathways in head and neck cancers.

57 Relaxins enhance growth of spontaneous murine breast cancers as well as metastatic colonization of the brain.

58 Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers

59 Breast Magnetic Resonance Spectroscopy at 3 T in Biopsy-Proven Breast Cancers: Does Choline Peak Correlate With Prognostic Factors?

60 Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4.

61 A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

62 RNA-seq reveals more consistent reference genes for gene expression studies in human non-melanoma skin cancers

63 A three-year study of epidemiological trends of gastrointestinal cancers in a Haitian cancer program.

64 Relative burden of lung and pleural cancers from exposure to asbestos: a cross-sectional analysis of occupational mortality in England and Wales.

65 MiRNA-106b-5p in human cancers: diverse functions and promising biomarker.

66 Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

67 Early gastrointestinal cancers

68 A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers

69 Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

70 Peroxiredoxin II Regulates Cancer Stem Cells and Stemness-Associated Properties of Cancers

71 gene co-expression analyses differentiate networks associated with diverse cancers harbouring tp53 missense or null mutations

72 study of conducting low-dose chest computed tomography and p16 gene methylation in serum for early diagnosis of lung cancers

73 carcinomas mamários de tipo basal: perfil clínico-patológico e evolutivo basal-like breast cancers: clinicopathological features and outcome

74 malignancy-associated regions of transcriptional activation: gene expression profiling identifies common chromosomal regions of a recurrent transcriptional activation in human prostate, breast, ovarian, and colon cancers

75 tailoring dna vaccines: designing strategies against her2 positive cancers

76 recent advances in chemotherapy for head and neck cancers

77 en bloc pancreaticoduodenectomy for locally advanced right colon cancers

78 identification of known and novel recurrent viral sequences in data from multiple patients and multiple cancers

79 erratum: benelli, r., et al. aspartate-β-hydroxylase: a promising target to limit the local invasiveness of colorectal cancer. cancers 2020, 12, 971

80 transfusion therapy in the radical surgical treatment of patients with urinary bladder and prostate cancers

81 immunotherapy plus cryotherapy: potential augmented abscopal effect for advanced cancers

82 overcoming heterogeneity of antigen expression for effective car t cell targeting of cancers

83 utilization of microsatellites for the analysis of genomic alterations in colorectal cancers in brazil

84 reducing sun exposure for prevention of skin cancers: factorial invariance and reliability of the self-efficacy scale for sun protection

85 the effect of circulating mir-223 on surveillance of different cancers: a meta-analysis

86 association between ape1 asp148glu polymorphism and the risk of urinary cancers: a meta-analysis of 18 case–control studies

87 new international federation of gynecology and obstetrics (figo) staging system of gynecological cancers

88 Effects of extracts and molecules derived from medicinal plants of West Africa in the prevention and treatment of gynecological cancers. A Review.

89 goniothalamus species: a source of drugs for the treatment of cancers and bacterial infections?

90 quantum dots immunofluorescence histochemical detection of egfr gene mutations in the non-small cell lung cancers using mutation-specific antibodies

91 the genetics of neuroendocrine prostate cancers: a review of current and emerging candidates

92 vascular permeability and drug delivery in cancers

93 real-time tracking of ex vivo-expanded natural killer cells toward human triple-negative breast cancers

94 is human papilloma virus positivity in oropharyngeal cancers a game changer in indian subcontinent?

95 new biomarkers for oral cancers in taiwan

96 targeting mdm4 splicing in cancers

97 transoral laser surgery for supraglottic squamous cancers

98 classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cdna microarray analysis

99 strengthening care and research for women's cancers in sub-saharan africa

100 blood genome-wide transcriptional profiles of her2 negative breast cancers patients

101 epidemiological aspects of head and neck cancers in a population of south east region of iran

Keyword Connections

Journals

Research Groups

Bibliographies